IMC Chicago’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$447K Sell
3,945
-509
-11% -$50.5K ﹤0.01% 4779
2026
Q1
$419K Buy
+4,454
New +$444K ﹤0.01% 4230
2024
Q4
Sell
-10,175
Closed -$673K 3243
2024
Q3
$673K Sell
10,175
-4,809
-32% -$307K ﹤0.01% 2261
2024
Q2
$908K Sell
14,984
-2,775
-16% -$157K ﹤0.01% 2013
2024
Q1
$1.01M Buy
+17,759
New +$1.07M ﹤0.01% 1735
2019
Q1
Sell
-8,539
Closed -$695K 769
2018
Q4
$543K Buy
+8,539
New +$554K ﹤0.01% 592

Other funds holding INCY

IMC Chicago's INCY Position: Q2 2026 in Review

IMC Chicago reduced its Incyte (INCY) stake by 11% in Q2 2026, selling an estimated $50.5K and leaving 3,945 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #4779.

IMC Chicago first reported a position in INCY in Q4 2018 and has held it in 6 quarters since. The position peaked at $1.01M in Q1 2024. 471 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • IMC Chicago held 3,945 shares of Incyte worth $447K as of Q2 2026.
  • IMC Chicago sold 509 Incyte shares in Q2 2026, an estimated $50.5K.
  • Incyte made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4779 holding.
  • IMC Chicago first reported a position in Incyte in Q4 2018 and has held it in 6 quarters since.
  • IMC Chicago's Incyte position peaked at $1.01M in Q1 2024.
  • 471 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.